Stephanie Markovina: Drug Discovery Efforts Targeting SERPINB3 for Biomarker Driven Cancer Therapy at AACR 2026
Stephanie Markovina and Sarah Yu

Stephanie Markovina: Drug Discovery Efforts Targeting SERPINB3 for Biomarker Driven Cancer Therapy at AACR 2026

Stephanie Markovina, Associate Professor, Vice Chair of Research of Department of Radiation Oncology at Washington University in St. Louis, shared a post on X:

“So proud of Washington University in St. Louis undergrad Sarah Yu (pictured with her mentor Michelle Chen) who presented our drug discovery efforts to target SERPINB3 for biomarker-driven cancer therapy at AACR 2026.

Look out for her on the med school interview circuit next year!!”

Stephanie Markovina: Drug Discovery Efforts Targeting SERPINB3 for Biomarker Driven Cancer Therapy at AACR 2026

More posts about AACR 2026.